{"id":"W2043370987","doi":"10.1038/ki.2008.629","title":"A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura","year":2009,"lang":"en","type":"review","venue":"Kidney International","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Hamilton Health Sciences; University Health Network; Canadian Apheresis Group; London Health Sciences Centre; McMaster University","funders":"","keywords":"Rituximab; Medicine; Thrombotic thrombocytopenic purpura; Immunosuppression; ADAMTS13; Immunology; Refractory (planetary science); Monoclonal antibody; Thrombocytopenic purpura; Von Willebrand factor; Antibody; Internal medicine; Platelet","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001770462,0.0006496217,0.002565446,0.0005037097,0.0002437357,0.0007398811,0.00127088,0.000835647,0.0013914],"category_scores_gemma":[0.001167759,0.0001417271,0.0007996522,0.00100486,0.0003754688,0.0002895871,0.0002660413,0.001319718,0.0002330976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002272704,"about_ca_system_score_gemma":0.004061308,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02413055,"about_ca_topic_score_gemma":0.06294812,"domain_scores_codex":[0.9996905,0.00008863204,0.00002781666,0.00003318399,0.0001176657,0.00004234247],"domain_scores_gemma":[0.999414,0.0002173676,0.00008596148,0.0000142193,0.000180612,0.00008778727],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.007593707,0.0004671205,0.0009572267,0.01447589,0.001411499,0.0005917805,0.00008901481,0.0004993947,0.003758064,0.0005439332,0.03375374,0.9358587],"study_design_scores_gemma":[0.04331595,0.01690857,0.03943677,0.01372151,0.01194721,0.005045305,0.000247858,0.0008408532,0.005139395,0.001006907,0.8622347,0.0001550782],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.00543438,0.9915912,0.0001592413,0.0006595905,0.0003074621,0.0001040605,0.0001048376,0.000009338212,0.00162988],"genre_scores_gemma":[0.03770534,0.9565688,0.001008522,0.002260966,0.0003568587,0.0001025655,0.0004700029,0.000007040925,0.001519965],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9758695,"threshold_uncertainty_score":0.04798019,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05357560575945004,"score_gpt":0.3763391755558815,"score_spread":0.3227635697964315,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}